Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

En studie för att bedöma förändring i sjukdomsaktivitet och biverkningar av oral upadacitinib hos vuxna och ungdomar med måttlig till svår Hidradenitis Suppurativa som har misslyckats med anti-TNF-terapi (Step-Up HS)

10 november 2026 uppdaterad av: AbbVie

En fas 3, randomiserad, placebokontrollerad, dubbelblind studie för att utvärdera effektivitet och säkerhet av Upadacitinib hos vuxna och ungdomar med måttlig till svår Hidradenitis Suppurativa som har misslyckats med anti-TNF-terapi

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how safe and effective upadacitinib is in treating adult and adolescent participants with moderate to severe HS who have failed to respond to or are intolerant of anti-tumor necrosis factor (TNF) therapy. Adverse events and change in disease activity will be assessed.

Upadacitinib is an approved drug for ulcerative colitis, atopic dermatitis, rheumatoid arthritis, psoriatic arthritis, and axial spondylarthritis and is being developed for the treatment of HS. This study is "double-blinded", meaning that neither the trial participants nor the study doctors will know who will be given upadacitinib and who will be given placebo. This study is comprised of 3 periods. In Period 1, participants are randomized into 2 groups called treatment arms where each group receives a different treatment. There is a 1 in 2 chance that participants will be assigned to placebo. In Period 2, participants are placed into 6 different groups depending on their placement and results in Period 1. Period 3 is the long-term extension period where participants will continue treatment from Period 2. Approximately 1328 adult and adolescent participants diagnosed with HS will be enrolled in approximately 300 sites worldwide.

Participants will receive oral tablets of upadacitinib or placebo once daily for 36 weeks in Period 1 and Period 2. Eligible participants from Period 1 and Period 2 will enter Period 3 and receive oral tablets of upadacitinib or placebo once daily for 68 weeks. Participants will be followed up for approximately 30 days.

There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular outpatient visits during the study. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.

Studieöversikt

Status

Aktiv, inte rekryterande

Studietyp

Interventionell

Inskrivning (Beräknad)

1328

Fas

  • Fas 3

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Buenos Aires, Argentina, 1061
        • Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 255474
      • CABA, Argentina, C1199ABB
        • Hospital Italiano /ID# 254905
    • Buenos Aires
      • Pilar, Buenos Aires, Argentina, 1629
        • Hospital Universitario Austral /ID# 254904
    • Buenos Aires F.D.
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1055
        • Buenos Aires Skin /ID# 255299
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1425
        • Instituto de Neumonologia y Dermatologia /ID# 254903
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1425
        • Psoriahue Med Interdisciplinar /ID# 257202
      • Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1428
        • Consultorios Reumatologicos Pampa /ID# 255555
    • Australian Capital Territory
      • Phillip, Australian Capital Territory, Australien, 2606
        • Paratus Clinical Research Woden /ID# 254670
    • New South Wales
      • Darlinghurst, New South Wales, Australien, 2010
        • Momentum Clinical Research /ID# 254411
    • Victoria
      • Carlton, Victoria, Australien, 3053
        • Skin Health Institute Inc /ID# 254416
      • East Melbourne, Victoria, Australien, 3002
        • Sinclair Dermatology - Melbourne /ID# 254412
      • Melbourne, Victoria, Australien, 3004
        • The Alfred Hospital /ID# 254414
      • Liège, Belgien, 4000
        • CHU de Liege /ID# 254085
    • Brussels Capital
      • Anderlecht, Brussels Capital, Belgien, 1070
        • Universite Libre de Bruxelles - Hopital Erasme /ID# 254082
      • Brussels, Brussels Capital, Belgien, 1200
        • Cliniques Universitaires UCL Saint-Luc /ID# 254087
      • Jette, Brussels Capital, Belgien, 1090
        • Universitair Ziekenhuis Brussel /ID# 254223
    • Hainaut
      • Charleroi, Hainaut, Belgien, 6280
        • Grand Hopital de Charleroi - Les Viviers /ID# 254091
    • Oost-Vlaanderen
      • Ghent, Oost-Vlaanderen, Belgien, 9000
        • UZ Gent /ID# 254090
    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Belgien, 3000
        • Universitair Ziekenhuis Leuven /ID# 254089
      • Rio de Janeiro, Brasilien, 20241-180
        • Instituto Brasil de Pesquisa Clinica S.A - IBPClin /ID# 275810
      • São Paulo, Brasilien, 05403-000
        • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 254370
    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasilien, 90035-001
        • Hospital Moinhos de Vento /ID# 254366
    • Rio de Janeiro
      • Macaé, Rio de Janeiro, Brasilien, 27910-190
        • Instituto de Pesquisa e Ensino CLIGEDIMUNO - IPEC /ID# 254369
    • São Paulo
      • Campinas, São Paulo, Brasilien, 13034-685
        • Hospital e Maternidade Celso Pierro - PUC-Campinas /ID# 275811
      • Ribeirão Preto, São Paulo, Brasilien, 14049-900
        • Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto /ID# 254367
      • São Paulo, São Paulo, Brasilien, 04020-060
        • Centro de Desenvolvimento em Estudos Clinicos Brasil - CDEC /ID# 254368
      • Sofia, Bulgarien, 1407
        • Acibadem City Clinic Tokuda University Hospital EAD /ID# 253331
      • Stara Zagora, Bulgarien, 6000
        • UMHAT Professor Stoyan Kirkovich /ID# 253328
    • Sofia
      • Sofiya, Sofia, Bulgarien, 1407
        • Ambulatory for Specialized Medical Care-IPSMC-skin and venereal diseases /ID# 253329
      • Sofiya, Sofia, Bulgarien, 1463
        • Diagnostic Consultative Centre (Dcc) - Foкus 5 /ID# 253327
    • Region Metropolitana Santiago
      • Las Condes, Region Metropolitana Santiago, Chile, 7580206
        • Centro Medico Skin Med SPA /ID# 254560
      • Santiago, Region Metropolitana Santiago, Chile, 8420383
        • Centro Internacional de Estudios Clinicos - CIEC /ID# 254559
      • Vitacura, Region Metropolitana Santiago, Chile, 7640881
        • Clinica Dermacross /ID# 254558
    • Santiago Metropolitan
      • Independencia, Santiago Metropolitan, Chile, 8380465
        • Fundacion Innovacion Cardiovascular /ID# 254561
    • Antioquia
      • Medellín, Antioquia, Colombia, 050012
        • Clinica De Inmunologia Y Genetica (Cige) /ID# 254797
      • Medellín, Antioquia, Colombia, 050016
        • IPS Suramericana SAS - IPS Sura San Diego /ID# 255064
    • Atlántico
      • Barranquilla, Atlántico, Colombia, 80002
        • Centro Integral de Reumatologia del Caribe SAS - Circaribe SAS /ID# 255278
    • Cundinamarca
      • Bogotá, Cundinamarca, Colombia, 110221
        • Centro de Investigacion en Reumatologia y especialidades Medicas S.A.S- CIREEM /ID# 254796
    • North Ostrobothnia
      • Oulu, North Ostrobothnia, Finland, 90220
        • Oulun yliopistollinen sairaala /ID# 253969
    • Pirkanmaa
      • Tampere, Pirkanmaa, Finland, 33100
        • Terveystalo Tampere /ID# 253968
    • Alpes-Maritimes
      • Nice, Alpes-Maritimes, Frankrike, 06202
        • Chu De Nice-Hopital Larchet II /ID# 253504
    • Gironde
      • Bordeaux, Gironde, Frankrike, 33000
        • Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Saint-Andre /ID# 254139
    • Marne
      • Reims, Marne, Frankrike, 51100
        • Polyclinique Courlancy /ID# 254680
    • Pays de la Loire Region
      • Nantes, Pays de la Loire Region, Frankrike, 44000
        • Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 254114
    • Rhone
      • Lyon, Rhone, Frankrike, 69003
        • HCL - Hopital Edouard Herriot /ID# 253500
    • Île-de-France Region
      • Antony, Île-de-France Region, Frankrike, 92160
        • Hopital Prive d'Antony /ID# 253501
    • Alabama
      • Birmingham, Alabama, Förenta staterna, 35244
        • Cahaba Dermatology and Skin Health Center /ID# 254876
    • Arizona
      • Fountain Hills, Arizona, Förenta staterna, 85268
        • Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272564
      • Phoenix, Arizona, Förenta staterna, 85006
        • Medical Dermatology Specialists /ID# 254226
      • Scottsdale, Arizona, Förenta staterna, 85259
        • Mayo Clinic Hospital Scottsdale /ID# 254388
      • Tucson, Arizona, Förenta staterna, 85718-1407
        • Banner University Medicine Dermatology /ID# 255853
    • Arkansas
      • Fayetteville, Arkansas, Förenta staterna, 72703
        • Clinical Trials Institute - Northwest Arkansas /ID# 254924
      • Hot Springs, Arkansas, Förenta staterna, 71913-6404
        • Burke Pharmaceutical Research /ID# 254238
      • North Little Rock, Arkansas, Förenta staterna, 72217
        • Arkansas Research Trials /ID# 254233
      • Rogers, Arkansas, Förenta staterna, 72758
        • Northwest Arkansas Clinical Trials Center /ID# 254311
    • California
      • Encino, California, Förenta staterna, 91436
        • Private Practice - Dr. Tooraj Raoof /ID# 254374
      • Huntington Beach, California, Förenta staterna, 92647
        • Marvel Clinical Research /ID# 276228
      • Los Angeles, California, Förenta staterna, 90045
        • Dermatology Research Associates /ID# 254846
      • Rocklin, California, Förenta staterna, 95765
        • Norcal Clinical Research /ID# 274219
      • Sacramento, California, Förenta staterna, 95815
        • Integrative Skin Science and Research /ID# 254930
      • Sacramento, California, Förenta staterna, 95817
        • University of California Davis Health /ID# 254229
      • San Diego, California, Förenta staterna, 92103
        • Medderm Associates /ID# 253800
      • Thousand Oaks, California, Förenta staterna, 91320-2130
        • Clinical Trials Research Institute /ID# 254466
    • Connecticut
      • Farmington, Connecticut, Förenta staterna, 06032
        • UConn Health Main /ID# 254507
      • New Haven, Connecticut, Förenta staterna, 06510
        • Yale University School of Medicine /ID# 254586
    • Florida
      • Boca Raton, Florida, Förenta staterna, 33486-2269
        • Skin Care Research Boca Raton /ID# 253814
      • Brandon, Florida, Förenta staterna, 33511
        • Apex Clinical Trials /ID# 255756
      • Coral Gables, Florida, Förenta staterna, 33134-5755
        • Florida Academic Dermatology Center /ID# 254011
      • Coral Springs, Florida, Förenta staterna, 33071
        • Life Clinical Trials - Coral Springs /ID# 258613
      • Delray Beach, Florida, Förenta staterna, 33445
        • Dermatology Associates of the Palm Beaches /ID# 275950
      • Hollywood, Florida, Förenta staterna, 33021-6748
        • Skin Care Research - Hollywood /ID# 254508
      • Tampa, Florida, Förenta staterna, 33607-6438
        • Skin Care Research - Tampa /ID# 256440
      • Tampa, Florida, Förenta staterna, 33607
        • Advanced Clinical Research Institute - Tampa /ID# 253746
      • Tampa, Florida, Förenta staterna, 33613-1825
        • Avita Clinical Research /ID# 254471
    • Georgia
      • Columbus, Georgia, Förenta staterna, 31904-2954
        • Centricity Research - Columbus /ID# 255470
    • Idaho
      • Boise, Idaho, Förenta staterna, 83706
        • Treasure Valley Medical Research /ID# 255208
    • Illinois
      • Chicago, Illinois, Förenta staterna, 60602
        • Illinois Dermatology Institute - Chicago Loop Office /ID# 254372
      • Chicago, Illinois, Förenta staterna, 60611
        • Northwestern Medicine - Northwestern Memorial Hospital /ID# 254503
      • Skokie, Illinois, Förenta staterna, 60077
        • NorthShore University HealthSystem - Skokie /ID# 254389
    • Indiana
      • Indianapolis, Indiana, Förenta staterna, 46256
        • Dawes Fretzin /ID# 254390
      • West Lafayette, Indiana, Förenta staterna, 47906
        • Options Research Group /ID# 254537
    • Kansas
      • Leawood, Kansas, Förenta staterna, 66211-1453
        • U.S. Dermatology Partners Leawood /ID# 255838
    • Kentucky
      • Bowling Green, Kentucky, Förenta staterna, 42104
        • Equity Medical /ID# 271140
    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02114
        • Massachusetts General Hospital /ID# 261093
      • Boston, Massachusetts, Förenta staterna, 02215-5400
        • Beth Israel Deaconess Medical Center /ID# 253811
      • Quincy, Massachusetts, Förenta staterna, 02169
        • Beacon Clinical Research, LLC /ID# 254419
      • Worcester, Massachusetts, Förenta staterna, 01655
        • UMass Memorial Medical Center - Lake Avenue North /ID# 258839
    • Michigan
      • Caledonia, Michigan, Förenta staterna, 49316
        • The Derm Institute Of West Michigan /ID# 275948
      • Canton, Michigan, Förenta staterna, 48187
        • Hamzavi Dermatology - Canton /ID# 275856
      • Clarkston, Michigan, Förenta staterna, 48346
        • Michigan Center for Medical Research - Clarkston /ID# 275860
      • Waterford, Michigan, Förenta staterna, 48328
        • Michigan Dermatology Institute /ID# 254468
    • Missouri
      • Kirksville, Missouri, Förenta staterna, 63501-5362
        • Cleaver Dermatology /ID# 254391
      • Lee's Summit, Missouri, Förenta staterna, 64064-2301
        • Dermatology and Skin Center of Lees Summit /ID# 257546
      • Saint Joseph, Missouri, Förenta staterna, 64506
        • MediSearch Clinical Trials /ID# 254392
      • St Louis, Missouri, Förenta staterna, 63104
        • SSM Health Saint Louis University Hospital /ID# 256437
      • St Louis, Missouri, Förenta staterna, 63130
        • Washington University School of Medicine - St. Louis /ID# 254506
    • Nevada
      • Las Vegas, Nevada, Förenta staterna, 89119-5190
        • Vivida Dermatology- Flamingo /ID# 254227
      • Las Vegas, Nevada, Förenta staterna, 89144
        • Las Vegas Dermatology /ID# 272421
      • Reno, Nevada, Förenta staterna, 89509
        • Skin Cancer and Dermatology Institute - Reno /ID# 254410
    • New York
      • East Syracuse, New York, Förenta staterna, 13057
        • Empire Dermatology /ID# 276241
      • New Hyde Park, New York, Förenta staterna, 11042-2058
        • NorthWell Health - Dermatology /ID# 254704
      • New York, New York, Förenta staterna, 07044-2946
        • Schweiger Dermatology, P.C. /ID# 254232
      • New York, New York, Förenta staterna, 10012
        • Private Practice - Dr. Bobby Buka /ID# 276371
    • North Carolina
      • Charlotte, North Carolina, Förenta staterna, 28277
        • OnSite Clinical Solutions - North Community House Road - Charlotte /ID# 254854
      • Durham, North Carolina, Förenta staterna, 27710
        • Duke University Medical Center /ID# 256898
    • Ohio
      • Canton, Ohio, Förenta staterna, 44718
        • Apex Clinical Research Center, LLC /ID# 275956
      • Columbus, Ohio, Förenta staterna, 43213-4440
        • ClinOhio Research Services /ID# 254851
      • Mason, Ohio, Förenta staterna, 45040-4520
        • Dermatologists of Southwest Ohio /ID# 254297
      • Medina, Ohio, Förenta staterna, 44256
        • Dermatology Partners - Medina /ID# 275939
    • Oklahoma
      • Oklahoma City, Oklahoma, Förenta staterna, 73112
        • Lynn Institute of Oklahoma City /ID# 253791
    • Oregon
      • Portland, Oregon, Förenta staterna, 97239
        • Oregon Health and Science University /ID# 254929
    • Pennsylvania
      • Hershey, Pennsylvania, Förenta staterna, 17033-2360
        • Penn State Milton S. Hershey Medical Center /ID# 254925
      • Philadelphia, Pennsylvania, Förenta staterna, 19103
        • Paddington Testing Co., Inc. /ID# 254394
      • Philadelphia, Pennsylvania, Förenta staterna, 19114
        • Clinical Research of Philadelphia, LLC /ID# 255308
    • South Carolina
      • Charleston, South Carolina, Förenta staterna, 29425
        • Medical University of South Carolina /ID# 272569
    • Tennessee
      • Knoxville, Tennessee, Förenta staterna, 37917
        • Dermatology Associates of Knoxville /ID# 261082
    • Texas
      • Arlington, Texas, Förenta staterna, 76011
        • Arlington Research Center, Inc /ID# 253805
      • Bellaire, Texas, Förenta staterna, 77401
        • Bellaire Dermatology Associates /ID# 253797
      • Dallas, Texas, Förenta staterna, 75230
        • Dermatology Treatment and Research Center /ID# 253795
      • Dallas, Texas, Förenta staterna, 75231
        • Modern Research Associates /ID# 253810
      • Dallas, Texas, Förenta staterna, 75240-6246
        • HRMD Research Dallas /ID# 255256
      • Grapevine, Texas, Förenta staterna, 76051-3580
        • Dallas Fort Worth Clinical Research Associates (DFWCRA) /ID# 256438
      • Houston, Texas, Förenta staterna, 77056
        • Suzanne Bruce and Associates-Houston /ID# 254228
      • Plano, Texas, Förenta staterna, 75025
        • Texas Dermatology Research Center /ID# 254928
      • Webster, Texas, Förenta staterna, 77598
        • Center for Clinical Studies Webster /ID# 254242
    • Utah
      • Bountiful, Utah, Förenta staterna, 84010
        • Cope Family Medicine - Ogden Clinic /ID# 276227
      • Murray, Utah, Förenta staterna, 84107
        • University of Utah - Murray /ID# 254452
      • Springville, Utah, Förenta staterna, 84663
        • Springville Dermatology - Springville /ID# 276225
    • Virginia
      • Charlottesville, Virginia, Förenta staterna, 22903
        • University of Virginia - Dermatology /ID# 254535
      • Lynchburg, Virginia, Förenta staterna, 24501-1403
        • The Education & Research Foundation, Inc. /ID# 254852
      • Norfolk, Virginia, Förenta staterna, 23507
        • Virginia Clinical Research /ID# 254538
    • Washington
      • Mill Creek, Washington, Förenta staterna, 98012
        • Frontier Dermatology /ID# 254554
      • Spokane, Washington, Förenta staterna, 99202
        • Premier Clinical Research /ID# 254847
      • Thessaloniki, Grekland, 54643
        • Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 253497
      • Thessaloniki, Grekland, 56429
        • Papageorgiou General Hospital /ID# 253496
    • Attica
      • Athens, Attica, Grekland, 11527
        • 401 GSNA - 401 Army General Hospital /ID# 253499
      • Athens, Attica, Grekland, 16121
        • General Hospital Andreas Syggros /ID# 253498
      • Chaïdári, Attica, Grekland, 12462
        • University General Hospital Attikon /ID# 253495
      • Cork, Irland, T12 X23H
        • South Infirmary Victoria University Hospital /ID# 253975
      • Dublin, Irland, D04 T6F4
        • St. Vincent's University Hospital /ID# 253971
      • Galway, Irland, H91 YR71
        • University Hospital Galway /ID# 253976
      • Waterford, Irland, X91 ER8E
        • Waterford Regional Hospital /ID# 254038
    • Dublin
      • Dublin, Dublin, Irland, D08 NHY1
        • St James Hospital /ID# 253973
      • Haifa, Israel, 3109601
        • Rambam Health Care Campus /ID# 254406
    • Central District
      • Petah Tikva, Central District, Israel, 4941492
        • Rabin Medical Center. /ID# 254405
    • Northern District
      • Safed, Northern District, Israel, 13100
        • ZIV Medical Center /ID# 254403
    • Tel Aviv
      • Ramat Gan, Tel Aviv, Israel, 52621
        • Sheba Medical Center /ID# 254545
      • Tel Aviv, Tel Aviv, Israel, 6423906
        • Tel Aviv Sourasky Medical Center /ID# 254404
      • Brescia, Italien, 25123
        • ASST degli Spedali Civili di Brescia /ID# 254875
      • Milan, Italien, 20122
        • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 254502
      • Modena, Italien, 41124
        • Azienda Ospedaliero-Universitaria di Modena /ID# 254874
      • Pisa, Italien, 56126
        • Azienda Ospedaliero Universitaria Pisana /ID# 254501
    • Ferrara
      • Cona, Ferrara, Italien, 44124
        • Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale S.Anna /ID# 254496
    • Firenze
      • Florence, Firenze, Italien, 50122
        • AZIENDA USL TOSCANA CENTRO - Ospedale Piero Palagi /ID# 254495
    • L Aquila
      • L’Aquila, L Aquila, Italien, 67100
        • ASL 1 Abruzzo - Ospedale regionale San Salvatore /ID# 276045
    • Roma
      • Rome, Roma, Italien, 00133
        • Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 254498
      • Rome, Roma, Italien, 00168
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 254500
    • Fukuoka
      • Fukuoka, Fukuoka, Japan, 814-0180
        • Fukuoka University Hospital /ID# 254729
    • Hyōgo
      • Nishinomiya-shi, Hyōgo, Japan, 663-8186
        • Meiwa Hospital /ID# 254728
    • Ibaraki
      • Tsukuba, Ibaraki, Japan, 305-8576
        • University of Tsukuba Hospital /ID# 254638
    • Kyoto
      • Kyoto, Kyoto, Japan, 602-8566
        • University Hospital Kyoto Prefectural University of Medicine /ID# 254481
    • Miyagi
      • Sendai, Miyagi, Japan, 9808574
        • Tohoku University Hospital /ID# 254598
    • Okinawa
      • Ginowan-shi, Okinawa, Japan, 901-2725
        • University of the Ryukyus Hospital /ID# 254517
    • Osaka
      • Sakai-shi, Osaka, Japan, 590-0197
        • Kindai University Hospital /ID# 254574
    • Shiga
      • Ōtsu, Shiga, Japan, 520-2192
        • Shiga University of Medical Science Hospital /ID# 254215
    • Tokyo
      • Minato-ku, Tokyo, Japan, 105-8470
        • Toranomon Hospital /ID# 253819
      • tabashi City, Tokyo, Japan, 173-8610
        • Nihon University Itabashi Hospital /ID# 254637
      • Québec, Kanada, G1V 4T3
        • Diex Recherche Quebec Inc. /ID# 254381
    • Alberta
      • Calgary, Alberta, Kanada, T2J 7E1
        • Dermatology Research Institute - Blackfoot Trail /ID# 261413
      • Calgary, Alberta, Kanada, T3A 2N1
        • Beacon Dermatology /ID# 254564
      • Edmonton, Alberta, Kanada, T5J 3S9
        • Rejuvenation Dermatology - Edmonton Downtown /ID# 254715
      • Edmonton, Alberta, Kanada, T6G 1C3
        • Alberta Dermasurgery Centre /ID# 275945
      • Red Deer, Alberta, Kanada, T4P 1K4
        • Care Clinic - Red Deer - Taylor Drive /ID# 276063
    • British Columbia
      • Surrey, British Columbia, Kanada, V3R 6A7
        • Dr. Chih-ho Hong Medical Inc. /ID# 254378
      • Surrey, British Columbia, Kanada, V3V 0C6
        • Enverus Medical Research /ID# 254380
    • Manitoba
      • Winnipeg, Manitoba, Kanada, R3M 3Z4
        • Wiseman Dermatology Research /ID# 254117
    • Newfoundland and Labrador
      • St. John's, Newfoundland and Labrador, Kanada, A1A 4Y3
        • Karma Clinical Trials /ID# 254120
    • Ontario
      • Hamilton, Ontario, Kanada, L8L 3C3
        • LEADER Research /ID# 254379
      • London, Ontario, Kanada, N6H 5L5
        • DermEffects /ID# 254116
      • Markham, Ontario, Kanada, L3P 1X2
        • Lynderm Research /ID# 254713
      • Mississauga, Ontario, Kanada, L4W 0C2
        • Derm Care Clinic /ID# 276065
      • Newmarket, Ontario, Kanada, L3Y 5G8
        • Ryan Clinical Research Inc /ID# 254714
      • Richmond Hill, Ontario, Kanada, L4C 9M7
        • York Dermatology Clinic and Research Centre /ID# 254115
      • Toronto, Ontario, Kanada, M4W 2N4
        • Research Toronto /ID# 255273
    • Quebec
      • Montreal, Quebec, Kanada, H3T 1C5
        • Centre Hospitalier Universitaire (CHU) Sainte-Justine /ID# 254118
      • Saint-Jérôme, Quebec, Kanada, J7Z 7E2
        • Dre Angelique Gagne-Henley M.D. inc. /ID# 255632
    • Saskatchewan
      • Saskatoon, Saskatchewan, Kanada, S7K 0H6
        • SkinSense Dermatology /ID# 254119
    • City of Zagreb
      • Zagreb, City of Zagreb, Kroatien, 10000
        • DermaPlus - Poliklinika za dermatologiju i venerologiju /ID# 253587
      • Zagreb, City of Zagreb, Kroatien, 10000
        • Klinicki bolnicki centar Zagreb /ID# 253786
      • Zagreb, City of Zagreb, Kroatien, 10000
        • Klinika za dječje bolesti Zagreb /ID# 253588
      • Zagreb, City of Zagreb, Kroatien, 10000
        • Poliklinika Solmed /ID# 254732
    • Primorje-Gorski Kotar County
      • Rijeka, Primorje-Gorski Kotar County, Kroatien, 51000
        • Specialty Hospital Medico /ID# 254731
    • Split-Dalmatia County
      • Split, Split-Dalmatia County, Kroatien, 21000
        • Klinicki Bolnicki Centar Split /ID# 253789
    • Zagreb County
      • Ivanić-Grad, Zagreb County, Kroatien, 10310
        • Naftalan - Specijalna bolnica za medicinsku rehabilitaciju /ID# 253586
      • Vilnius, Litauen, 08406
        • Inlita - Santara KTC /ID# 253917
      • Vilnius, Litauen, 08661
        • Vilnius University Hospital Santaros Klinikos /ID# 253916
      • Mexico City, Mexiko, 06100
        • Cryptex Investigacion Clinica S.A de C.V /ID# 256066
    • Jalisco
      • Guadalajara, Jalisco, Mexiko, 44657
        • Grupo Clinico Catei Sociedad Civil /Id# 254657
    • Nuevo León
      • Monterrey, Nuevo León, Mexiko, 64718
        • Eukarya PharmaSite, SC /ID# 254658
      • Groningen, Nederländerna, 9713 GZ
        • Universitair Medisch Centrum Groningen /ID# 253571
    • North Brabant
      • Breda, North Brabant, Nederländerna, 4818 CK
        • Amphia Ziekenhuis /ID# 253567
    • Auckland
      • Epsom, Auckland, Nya Zeeland, 1051
        • Greenlane Clinical Centre /ID# 254351
    • Waikato Region
      • Hamilton, Waikato Region, Nya Zeeland, 3204
        • Clinical Trials New Zealand /ID# 254352
      • Lisbon, Portugal, 1998-018
        • Hospital CUF Descobertas /ID# 254323
      • Porto, Portugal, 4099-001
        • Centro Hospitalar Universitario do Porto, EPE - Hospital Santo Antonio /ID# 254322
      • Porto, Portugal, 4200-319
        • Unidade Local de Saude Sao Joao /ID# 254324
    • Lisbon District
      • Lisbon, Lisbon District, Portugal, 1169-050
        • Centro Hospitalar de Lisboa Central - Lisbon /ID# 254325
      • Caguas, Puerto Rico, 00727
        • Dr. Samuel Sanchez PSC /ID# 253948
      • Carolina, Puerto Rico, 00985
        • Alma M. Cruz Santana, MD-Private practice /ID# 253951
      • Riyadh, Saudiarabien, 12372
        • King Saud University Med City /ID# 255282
    • Mecca Region
      • Jeddah, Mecca Region, Saudiarabien, 23433
        • King Faisal Specialist Hospital /ID# 255539
    • Riyadh Region
      • Riyadh, Riyadh Region, Saudiarabien, 11211
        • King Faisal Specialist Hospital and Research Centre /ID# 255279
      • Riyadh, Riyadh Region, Saudiarabien, 11426
        • King Abdulaziz Medical City- National Guard Hospital /ID# 255280
      • Bern, Schweiz, 3010
        • Inselspital, Universitaetsspital Bern /ID# 254736
    • Canton of St. Gallen
      • Sankt Gallen, Canton of St. Gallen, Schweiz, 9007
        • Kantonsspital St. Gallen /ID# 255243
    • Canton of Zurich
      • Zurich, Canton of Zurich, Schweiz, 8091
        • University Hospital Zurich /ID# 254642
      • Singapore, Singapore, 119074
        • National University Hospital /ID# 254943
    • Central Singapore
      • Singapore, Central Singapore, Singapore, 308205
        • National Skin Centre /ID# 255242
    • Bratislava Region
      • Bratislava, Bratislava Region, Slovakien, 821 01
        • Univerzitna nemocnica Bratislava - Nemocnica Ruzinov /ID# 254157
    • Košice Region
      • Košice, Košice Region, Slovakien, 041 90
        • Univerzitna nemocnica L. Pasteura Kosice /ID# 254136
    • Nitra Region
      • Nové Zámky, Nitra Region, Slovakien, 940 34
        • Fakultna nemocnica s poliklinikou Nove Zamky /ID# 254155
    • Trnava Region
      • Trnava, Trnava Region, Slovakien, 917 02
        • Fakultna nemocnica Trnava /ID# 254137
    • Žilina Region
      • Martin, Žilina Region, Slovakien, 036 01
        • Univerzitna nemocnica Martin /ID# 254153
      • Barcelona, Spanien, 08041
        • Hospital Santa Creu i Sant Pau /ID# 253869
      • Barcelona, Spanien, 08042
        • Hospital General de Granollers /ID# 253873
      • Granada, Spanien, 18014
        • Hospital Universitario Virgen de las Nieves /ID# 253870
      • Madrid, Spanien, 28034
        • Hospital Universitario Ramon y Cajal /ID# 253871
      • Valencia, Spanien, 46026
        • Hospital Universitario y Politecnico La Fe /ID# 253868
    • Barcelona
      • L'Hospitalet de Llobregat, Barcelona, Spanien, 08907
        • Hospital Universitari de Bellvitge /ID# 254982
    • Madrid
      • Majadahonda, Madrid, Spanien, 28222
        • Hospital Universitario Puerta de Hierro - Majadahonda /ID# 253924
    • Valencia
      • Manises, Valencia, Spanien, 46940
        • Hospital de Manises /ID# 253867
      • Bristol, Storbritannien, BS1 3NU
        • University Hospitals Bristol /ID# 261505
      • Salford, Storbritannien, M6 8HD
        • Northern Care Alliance NHS Group /ID# 256910
    • Greater London
      • Isleworth, Greater London, Storbritannien, TW7 6AF
        • West Middlesex University Hospital /ID# 254190
      • London, Greater London, Storbritannien, SW17 0QT
        • St George University Hospitals NHS Foundation Trust /ID# 256803
    • Hampshire
      • Southampton, Hampshire, Storbritannien, SO16 6YD
        • University Hospital Southampton NHS Foundation Trust /ID# 254531
    • Warwickshire
      • Coventry, Warwickshire, Storbritannien, CV2 2DX
        • UH Coventry & Warwickshire /ID# 256909
    • West Yorkshire
      • Leeds, West Yorkshire, Storbritannien, LS9 7TF
        • Leeds Teaching Hospitals NHS Trust /ID# 254616
    • Stockholm County
      • Solna, Stockholm County, Sverige, 171 64
        • Karolinska University Hospital Solna /ID# 254808
    • Västra Götaland County
      • Gothenburg, Västra Götaland County, Sverige, 413 46
        • Sahlgrenska Universitetssjukhuset /ID# 254807
    • Gyeonggido
      • Ansan-si, Gyeonggido, Sydkorea, 15355
        • Korea University Ansan Hospital /ID# 254128
      • Seongnam, Gyeonggido, Sydkorea, 13496
        • CHA Bundang Medical Center /ID# 254026
    • Seoul Teugbyeolsi
      • Seoul, Seoul Teugbyeolsi, Sydkorea, 03080
        • Seoul National University Hospital /ID# 254027
      • Seoul, Seoul Teugbyeolsi, Sydkorea, 04401
        • SoonChunHyang University Seoul Hospital /ID# 254025
      • Seoul, Seoul Teugbyeolsi, Sydkorea, 07441
        • Hallym University Kangnam Sacred Heart Hospital /ID# 254127
      • Changhua City, Changhua County, Taiwan, 50006
        • Changhua Christian Hospital /ID# 254032
      • Kaohsiung City, Taiwan, 833
        • Kaohsiung Chang Gung Memorial Hospital /ID# 254031
      • Taipei, Taiwan, 100
        • National Taiwan University Hospital /ID# 254030
      • Taoyuan City, Taiwan, 333
        • Linkou Chang Gung Memorial Hospital /ID# 254033
      • Karlovy Vary, Tjeckien, 360 01
        • Karlovarska Krajska Nemocnice - Karlovy Vary /ID# 253456
      • Prague, Tjeckien, 100 34
        • Fakultni nemocnice Kralovske Vinohrady /ID# 253454
    • Praha 5
      • Prague, Praha 5, Tjeckien, 150 06
        • Fakultni nemocnice Motol a Homolka /ID# 253455
      • Bayraklı, Turkiet (Türkiye), 35540
        • Izmir Sehir Hastanesi /ID# 265465
      • Bursa, Turkiet (Türkiye), 16059
        • Uludag University Medical Faculty /ID# 253806
      • Istanbul, Turkiet (Türkiye), 34098
        • Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi /ID# 253824
      • Kayseri, Turkiet (Türkiye), 38039
        • Erciyes University Medical Faculty /ID# 253804
      • Samsun, Turkiet (Türkiye), 55139
        • Ondokuz Mayis Universitesi /ID# 254034
    • Antalya
      • Ankara, Antalya, Turkiet (Türkiye), 06010
        • Gulhane Egitim ve Arastirma Hastanesi /ID# 253919
      • Berlin, Tyskland, 13595
        • Havelklinik /ID# 254194
      • Magdeburg, Tyskland, 39104
        • Magdeburger Company for Medical Studies & Services GmbH /ID# 255151
      • Mainz, Tyskland, 55128
        • Dermatologie Quist-BAG Dres. med. Quist PartG /ID# 253691
    • Baden-Wurttemberg
      • Freiburg im Breisgau, Baden-Wurttemberg, Tyskland, 79106
        • Universitaetsklinikum Freiburg /ID# 275746
    • Bavaria
      • Erlangen, Bavaria, Tyskland, 91054
        • Universitaetsklinikum Erlangen /ID# 254804
      • Munich, Bavaria, Tyskland, 80802
        • Klinikum rechts der Isar Technische Universitat Munchen /ID# 254195
      • Regensburg, Bavaria, Tyskland, 93042
        • Universitaetsklinikum Regensburg /ID# 253692
      • Würzburg, Bavaria, Tyskland, 97080
        • Universitaetsklinikum Wuerzburg /ID# 275599
    • Hesse
      • Frankfurt am Main, Hesse, Tyskland, 60590
        • Universitaetsklinikum Frankfurt /ID# 253683
    • Lower Saxony
      • Bad Bentheim, Lower Saxony, Tyskland, 48455
        • Fachklinik - Bad Bentheim /ID# 275537
      • Bramsche, Lower Saxony, Tyskland, 49565
        • Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 254510
    • North Rhine-Westphalia
      • Bochum, North Rhine-Westphalia, Tyskland, 44791
        • Universitaetsklinikum Der Ruhr-Universitaet Bochum /ID# 253690
      • Düsseldorf, North Rhine-Westphalia, Tyskland, 40225
        • Universitaetsklinikum Duesseldorf /ID# 253711
    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Tyskland, 55131
        • Universitaetsmedizin Mainz /ID# 272596
    • Saarland
      • Merzig, Saarland, Tyskland, 66663
        • Hautmedizin Saar Science /ID# 272614
      • Budapest, Ungern, 1027
        • Csalogany Orvosi Kozpont /ID# 255063
      • Budapest, Ungern, 1036
        • Duplicate_Obudai Egeszsegugyi Centrum Kft. /ID# 256366
      • Budapest, Ungern, 1085
        • Semmelweis Egyetem /ID# 276162
      • Debrecen, Ungern, 4031
        • DERMA-B Egeszsegugyi es Szolgaltato - Debrecen - Gyepusor Utca /ID# 253638
    • Baranya
      • Pécs, Baranya, Ungern, 7624
        • Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 253753
    • Csongrád megye
      • Szeged, Csongrád megye, Ungern, 6720
        • Szegedi Tudomanyegyetem /ID# 255142
    • Hajdú-Bihar
      • Debrecen, Hajdú-Bihar, Ungern, 4032
        • Debreceni Egyetem-Klinikai Kozpont /ID# 253637
    • Somogy County
      • Kaposvár, Somogy County, Ungern, 7400
        • Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 253913
    • Vas County
      • Szombathely, Vas County, Ungern, 9700
        • Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 254377
    • State of Vienna
      • Vienna, State of Vienna, Österrike, 1090
        • Medizinische Universitaet Wien /ID# 254096
    • Styria
      • Graz, Styria, Österrike, 8010
        • Medizinische Universitaet Graz /ID# 253448
    • Upper Austria
      • Linz, Upper Austria, Österrike, 4010
        • Duplicate_Ordensklinikum Linz GmbH Elisabethinen /ID# 253458

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

12 år och äldre (Barn, Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Diagnosis of hidradenitis suppurativa (HS) for at least 6 months prior to Baseline, as determined by the investigator (i.e., through medical history and interview of participant).
  • Documented history of previous use of >= 1 tumor necrosis factor (TNF) inhibitor for HS for at least 12 weeks and/or 1 approved non-anti-TNF biologic therapy for HS for at least 16 weeks characterized by inadequate response or for any duration characterized by intolerance as determined by the investigator.
  • Participant must have a total abscess and inflammatory nodule (AN) count of >= 5 at Baseline.
  • HS lesions must be present in at least 2 distinct anatomic areas at Baseline.
  • At least 1 anatomic area of HS involvement characterized as Hurley Stage II or higher at Baseline.
  • Draining fistula count of <= 20 at Baseline.

Exclusion Criteria:

  • History of active skin disease other than HS that could interfere with the assessment of HS, including skin infections (bacterial, fungal, or viral) requiring systemic treatment within 4 weeks of the Baseline visit.
  • Treatment with any investigational drug of chemical or biologic nature within a minimum of 30 days or 5 half-lives (whichever is longer) prior to the first dose of study drug or be currently enrolled in another interventional clinical study. Investigational drugs are also prohibited during the study.
  • Previous treatment with any cell-depleting therapies including but not limited to anti-CD20 (e.g., rituximab) within 12 months prior to Baseline or until B cell count returns to normal level or pre-treatment level.
  • Use of prescription topical therapies (including topical antibiotics) that can also be used to treat HS within 14 days prior to the Baseline visit.
  • Received any systemic (including oral) antibiotic treatment for HS or any other chronic inflammatory disorder within 14 days prior to the Baseline visit.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Fyrdubbla

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Period 1: Upadacitinib Dose A

Participants will receive Upadicitinib Dose A once daily for 16 weeks.

Oral Tablets

Andra namn:
  • RINVOQ
  • ABT-494
Placebo-jämförare: Period 1: Placebo

Participants will receive Placebo once daily for 16 weeks.

Oral Tablets

Experimentell: Period 2: Group 1 - Upadacitinib Dose A

Participants who were randomized to placebo in Period 1 who did not achieve HiSCR 50 (clinical non-responder, CNR) at Week 16 will receive Upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Andra namn:
  • RINVOQ
  • ABT-494
Placebo-jämförare: Period 2: Group 2 - Placebo

Participants who were randomized to placebo in Period 1 who achieve HiSCR 50 (clinical responder, CR) at Week 16 will continue to receive placebo once daily for 20 weeks.

Oral Tablets

Experimentell: Period 2: Group 3 - Upadacitinib Dose A

Participants who were randomized to upadacitinib Dose A in Period 1 who did not achieve HiSCR 50 (CNR) at Week 16 will continue to receive upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Andra namn:
  • RINVOQ
  • ABT-494
Experimentell: Period 2: Group 4 - Upadacitinib Dose A

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive upadacitinib Dose A once daily for 20 weeks.

Oral Tablets

Andra namn:
  • RINVOQ
  • ABT-494
Experimentell: Period 2: Group 5 - Upadacitinib Dose B

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive upadacitinib Dose B once daily for 20 weeks.

Oral Tablets

Andra namn:
  • RINVOQ
  • ABT-494
Experimentell: Period 2: Group 6 - Placebo

Participants who were randomized to upadacitinib Dose A in Period 1 who achieve HiSCR 50 (CR) at Week 16 will receive placebo once daily for 20 weeks.

Oral Tablets

Experimentell: Period 3: Long-Term Extension

Eligible participants will continue to receive upadacitinib or placebo for 68 weeks. Participants will be followed-up for approximately 30 days.

Oral Tablets

Andra namn:
  • RINVOQ
  • ABT-494

Oral Tablets

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR) 50
Tidsram: Baseline to Week 16

HiSCR 50 is defined as at least a 50% reduction in the total abscess and inflammatory nodule (AN) count with no increase in abscess count and no increase in draining fistula count relative to Baseline.

Baseline to Week 16
Number of Participants with Adverse Events (AEs)
Tidsram: Up to Approximately Week 108

An AE is defined as any untoward medical occurrence in a patient or clinical investigation in which a participant is administered a pharmaceutical product which does not necessarily have a causal relationship with this treatment.

Up to Approximately Week 108

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change from Baseline in Draining Fistula Count
Tidsram: Baseline to Week 16

Change from baseline in draining fistula count.

Baseline to Week 16
Percentage of Participants Achieving Hidradenitis Suppurative Clinical Response (HiSCR) 75
Tidsram: Baseline to Week 16

HiSCR 75 is defined as at least a 75% reduction in the total abscess and inflammatory nodule (AN) count with no increase in abscess count and no increase in draining fistula count relative to Baseline.

Baseline to Week 16
Percentage of Participants Achieving Numeric Rating Scale 30 (NRS30) at Week 4 Among Participants with NRS ≥ 3 at Baseline
Tidsram: Baseline to Week 4

Achievement will be considered at least a 30% reduction and at least 2 units reduction from Baseline in the Participant's Global Assessment (PGA) of HS-related skin pain NRS based on worst skin pain in a 24-hour recall period (maximal daily pain). The PGA Skin Pain is an 11-point numerical rating scale with ratings for the item ranging from 0 (no skin pain) to 10 (skin pain as bad as you can imagine).

Baseline to Week 4
Percentage of Participants Achieving NRS3 at Week 4 Among Participants with NRS ≥ 3 at Baseline
Tidsram: Baseline to Week 4

Achievement will be considered least 3 units reduction from Baseline in the Participant's Global Assessment (PGA) of HS-related skin pain NRS based on worst skin pain in a 24-hour recall period (maximal daily pain). The PGA Skin Pain is an 11-point numerical rating scale with ratings for the item ranging from 0 (no skin pain) to 10 (skin pain as bad as you can imagine).

Baseline to Week 4
Change from Baseline in Hidradenitis Suppurativa Symptom Assessment (HSSA)
Tidsram: Baseline to Week 16

The HSSA (24-hour recall) is a 9-item PRO questionnaire developed to assess the primary symptoms of HS in the 7 consecutive days prior to assessments. Each item of the HSSA is scored on an 11-point (0 to 10) NRS, where 0 represents no symptoms and 10 represents extreme symptom experience.

Baseline to Week 16
Change from Baseline in Hidradenitis Suppurativa Impact Assessment (HSIA)
Tidsram: Baseline to Week 16

The HSIA is an 18-item PRO questionnaire developed to assess the impact of HS on the daily lives of subjects in the 7 days prior to the assessment. Items 1 - 16 of the HSIA are scored on a 0 to 10 NRS, where 0 represents no impact and 10 represents extreme impact.

Baseline to Week 16
Change from Baseline in Dermatology Life Quality Index (DLQI) for Adult Participants and Adolescent Participants Age ≥16 Years Old and Older
Tidsram: Baseline to Week 16

The DLQI and the CDLQI are both 10-item questionnaires used to assess the impact of hidradenitis suppurativa (HS) disease symptoms and treatment on quality of life that consists of 10 questions scored on a 4-point scale where 0 = not at all/not relevant; 1 = a little; 2 = a lot; and 3 = very much.

Baseline to Week 16
Occurrence of Hidradenitis Suppurativa (HS) Flare During Period 1
Tidsram: Baseline to Week 16

Defined as at least one occurrence of a ≥ 25% increase in AN count, with a minimum absolute increase of 2 relative to Baseline.

Baseline to Week 16

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Utredare

  • Studierektor: ABBVIE INC., AbbVie

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

21 juni 2023

Primärt slutförande (Beräknad)

1 augusti 2028

Avslutad studie (Beräknad)

1 augusti 2028

Studieregistreringsdatum

Först inskickad

26 maj 2023

Först inskickad som uppfyllde QC-kriterierna

26 maj 2023

Första postat (Faktisk)

5 juni 2023

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

13 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

AbbVie is committed to responsible clinical trial data sharing. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information.

Tidsram för IPD-delning

For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/

Kriterier för IPD Sharing Access

To learn more about the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL
  • SAV

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Ja

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

produkt tillverkad i och exporterad från U.S.A.

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera